SPONSOR
University of California, Davis
Total Trials
5
Recruiting
5
Phases
Phase 1, Phase 2, Phase 4
Conditions studied: Metastatic Lobular Breast CarcinomaBreast CancerBreast Cancer Stage IBreast Cancer Stage IIBreast Cancer Stage IIIBreast Cancer Stage IVInvasive Breast CancerOvarian CancerOvarian Cancer Stage 1Ovarian Cancer Stage II
University of California, Davis is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Metastatic Lobular Breast Carcinoma, Breast Cancer, Breast Cancer Stage I, Breast Cancer Stage II.
The trial portfolio spans Phase 1, Phase 2, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — University of California, Davis
How many clinical trials has University of California, Davis sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by University of California, Davis, of which 5 are actively recruiting participants. These trials cover conditions including Metastatic Lobular Breast Carcinoma, Breast Cancer, Breast Cancer Stage I. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University of California, Davis research focus on?
University of California, Davis clinical trials span Metastatic Lobular Breast Carcinoma, Breast Cancer, Breast Cancer Stage I, Breast Cancer Stage II, Breast Cancer Stage III, and additional conditions. The research pipeline includes Phase 1, Phase 2, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University of California, Davis clinical trial?
To participate in a University of California, Davis trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of California, Davis trials with current recruitment status updated daily.
Clinical Trials by University of California, Davis
NCT07020806 Phase 1
Recruiting
[68Ga]Ga DOTA-5G as a Diagnostic Imaging Agent for Metastatic/Advanced Invasive Lobular Breast Cancer (LBC)
Metastatic Lobular Breast Carcinoma
NCT06268665 Phase 2
Recruiting
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy
Breast Cancer
NCT06990737 Phase 2
Recruiting
Phase 2 Pragmatic Trial of Sentinel Lymph Node Biopsy (SLNB) in Patients With Clinically Node-Negative (cN0), High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) of the Head and Neck
Cutaneous Squamous Cell Carcinoma of the Head and Neck
NCT07580183
Recruiting
Spatial Scene Recognition Memory in Epilepsy Surgery
Focal Epilepsy
NCT03737604 Phase 4
Recruiting
TAP Blocks With Ropivacaine Continuous Infusion Catheters vs Single Dose Liposomal Bupivicaine After Kidney Transplant
Transplant;Failure,Kidney
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology